Kyriat Ekron, Israel

Alex Weisman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Kiriat Ekron, IL (2013)
  • Kyriat Ekron, IL (2018 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alex Weisman: Innovator in Pharmaceutical Chemistry

Introduction

Alex Weisman is a notable inventor based in Kyriat Ekron, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid forms of ibrutinib. With a total of 3 patents to his name, Weisman has established himself as a key figure in the industry.

Latest Patents

Weisman’s latest patents focus on the solid forms of ibrutinib and the processes for their production. He has provided various polymorphs of ibrutinib, including crystalline forms III, IV, V, VI, VII, VIII, and IX. His work also includes the development of stable amorphous ibrutinib and methods for preparing these forms. Additionally, he has created pharmaceutical compositions that incorporate these crystalline and amorphous forms, along with methods for their use.

Career Highlights

Throughout his career, Alex Weisman has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with Wavelength Enterprises Ltd and Perrigo API Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Weisman has collaborated with various professionals in his field, including Sonia Krivonos and Itai Adin. These collaborations have further enhanced his research and development efforts in pharmaceutical chemistry.

Conclusion

Alex Weisman is a distinguished inventor whose work in the development of ibrutinib solid forms has made a significant impact in the pharmaceutical industry. His contributions continue to advance the field and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…